Palvella Therapeutics closes on Pieris merger; completes nearly $80M private placement
Wayne, Pa.-headquartered Palvella Therapeutics Inc. said on Dec. 13 it completed its merger with Boston-based biotechnology company Pieris Pharmaceuticals Inc. The transaction was approved by Pieri...
Read More